0001209191-22-041761.txt : 20220711
0001209191-22-041761.hdr.sgml : 20220711
20220711160015
ACCESSION NUMBER: 0001209191-22-041761
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220707
FILED AS OF DATE: 20220711
DATE AS OF CHANGE: 20220711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flannelly Barry P
CENTRAL INDEX KEY: 0001615842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 221076940
MAIL ADDRESS:
STREET 1: ROUTE 141 AND HENRY CLAY ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-07
0
0000879169
INCYTE CORP
INCY
0001615842
Flannelly Barry P
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP & General Manager US
Common Stock
2022-07-07
4
S
0
2873
79.38
D
72674
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Includes an aggregate of 48,281 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
/s/ Elizabeth Feeney, Attorney-In-Fact
2022-07-11